FDA Webview
X
about-us-banner

Pay Per View

Home / Pay Per View

10 Observations in Aurobindo Facility Inspection

[ Price : $8.95]

Aurobindo Pharma says FDA had 10 procedural observations from a pre-approval inspection at the firms new injectable facility in Ea...

Covid-19 Monoclonal Antibody EUA Guidance

[ Price : $8.95]

FDA publishes an immediately effective guidance with its latest recommendations for submissions to support an emergency use author...

Amazon Distributing Illegal Drugs: FDA

[ Price : $8.95]

FDA warns Amazon that its fulfillment service is distributing unapproved and misbranded new drugs labeled as energy-enhancing supp...

510(k) Third Party Review EUA Guidance

[ Price : $8.95]

FDA publishes a draft guidance on third-party review of 510(k)s and EUAs.

FDA Issuing Device Electronic Export Documents

[ Price : $8.95]

FDA says CDRH has begun issuing several types of electronic export documents for medical devices.

CGMP Violations in Inopak Inspection

[ Price : $8.95]

FDA warns Ringwood, NJ-based Inopak about CGMP violations in its production of finished drugs.

Clinical Hold on Iovance Lung Cancer Trial

[ Price : $8.95]

FDA places a clinical hold on Iovance Biotherapeutics IOV-LUN-202 clinical trial, which is assessing LN-145 tumor infiltrating lym...

Federal Register Notices from Holiday Break

[ Price : $8.95]

FDA Webview summarizes the Federal Register notices published during our holiday break.

Deep Flaws in FDA Device Oversight: KFF Health News

[ Price : $8.95]

A KFF Health News report on a year-long investigation into the FDA 510(k) medical device clearance pathway finds significant flaws...

Colonial Dames CGMP Violations

[ Price : $8.95]

FDA warns Commerce, CA-based Colonial Dames Company about repeat CGMP violations in its manufacture of misbranded and unapproved d...